238 related articles for article (PubMed ID: 23206896)
1. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
[TBL] [Abstract][Full Text] [Related]
2. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
[TBL] [Abstract][Full Text] [Related]
3. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
Eapen SS; Connor EL; Gern JE
Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
[TBL] [Abstract][Full Text] [Related]
4. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
[TBL] [Abstract][Full Text] [Related]
5. Insulin allergy desensitization with simultaneous intravenous insulin and continuous subcutaneous insulin infusion.
Neville KA; Verge CF; Wainstein BK; Woodhead HJ; Ziegler JB; Walker JL
Pediatr Diabetes; 2008 Aug; 9(4 Pt 2):420-2. PubMed ID: 18775000
[TBL] [Abstract][Full Text] [Related]
6. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
7. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
Nagai T; Nagai Y; Tomizawa T; Mori M
Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
[TBL] [Abstract][Full Text] [Related]
8. A practical, clinical approach to the assessment and management of suspected insulin allergy.
Jacquier J; Chik CL; Senior PA
Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
[TBL] [Abstract][Full Text] [Related]
9. Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.
Beltrand J; Guilmin-Crepon S; Castanet M; Peuchmaur M; Czernichow P; Levy-Marchal C
Horm Res; 2006; 65(5):253-60. PubMed ID: 16582568
[TBL] [Abstract][Full Text] [Related]
10. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
[TBL] [Abstract][Full Text] [Related]
11. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
Sahin SB; Cetinkalp S; Ozgen AG; Saygili F; Yilmaz C
Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
[TBL] [Abstract][Full Text] [Related]
12. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
13. Long-acting insulin allergy in a diabetic child.
Mastrorilli C; Rizzuti L; Cangelosi AM; Iovane B; Chiari G; Caffarelli C
Int J Immunopathol Pharmacol; 2017 Jun; 30(2):174-177. PubMed ID: 28368217
[TBL] [Abstract][Full Text] [Related]
14. Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion.
Moyes V; Driver R; Croom A; Mirakian R; Chowdhury TA
Diabet Med; 2006 Feb; 23(2):204-6. PubMed ID: 16433720
[TBL] [Abstract][Full Text] [Related]
15. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
16. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
17. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
18. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
19. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
